Harvard offers certain materials (usually biological research materials) for non-exclusive commercial use. Some materials, such as mice, are usually offered on a flat-rate basis or with fixed annual payments. Others, such as Hybridom cell lines, also include royalty-based payments. The standard agreements for both types of hardware licenses are available below. A reference to global access — the development of technologies from Harvard patents can lead to licensed products that could have significant public health benefits in developing countries. By participating in universities Allied for Essential Medicines, Harvard is committed to promoting affordable access to these products in developing countries. To fulfill this obligation, we may require provisions similar to those contained in the link below in exclusive licenses for such potentially effective technologies. An option agreement allows a company to “retain” a technology for a short period of time, during which time the company can continue to assess its potential or raise funds for product development without binding on the obligations of a licensing agreement or Harvard. Options typically have a term of six months to a year and typically require both a pre-fee and a refund of the patent application for the duration of the option….